Thomas Pincez

发表

Paediatric‐onset Evans syndrome: Breaking away from refractory immune thrombocytopenia

F. Rieux-Laucat, N. Aladjidi, T. Pincez, 2023, British journal of haematology.

Determinants of splenectomy long-term outcomes in pediatric autoimmune cytopenias.

G. Leverger, T. Leblanc, J. Stéphan, 2022, Blood.

Long term follow-up of pediatric-onset Evans syndrome: broad immunopathological manifestations and high treatment burden

F. Rieux-Laucat, C. Picard, G. Leverger, 2021, Haematologica.

Safety and efficacy of brentuximab vedotin as a treatment for lymphoproliferative disorders in primary immunodeficiencies

T. Molina, A. Fischer, E. Macintyre, 2019, Haematologica.

Genetic Modifiers of Sickle Cell Disease.

G. Lettre, A. Ashley-Koch, M. Telen, 2022, Hematology/oncology clinics of North America.

Neurological Involvement in Childhood Evans Syndrome

F. Rieux-Laucat, P. Varlet, G. Leverger, 2019, Journal of Clinical Immunology.

New MECOM variant in a child with severe neonatal cytopenias spontaneously resolving

C. Laverdière, J. Champagne, T. Pincez, 2020, Pediatric blood & cancer.

Feasibility and clinical integration of molecular profiling for target identification in pediatric solid tumors

O. Delattre, I. Bièche, V. Bernard, 2017, Pediatric blood & cancer.

Clinical-Scale Rapid Autologous BK Virus-Specific T Cell Line Generation From Kidney Transplant Recipients With Active Viremia for Adoptive Immunotherapy

L. Busque, A. Brasey, M. Goupil, 2017, Transplantation.